Patents by Inventor William M. Shannon

William M. Shannon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5431185
    Abstract: A fluid manifold includes a housing having a first inlet and an outlet and a plurality of inlets intermediate the first inlet and the outlet which are provided with check valve action to prevent retrograde flow through the valved inlets, yet allow individual inlets to pass fluid when the fluid pressure in any individual inlet exceeds that of the interior of the chamber by a predetermined cracking pressure. The check valve action is provided by a single resilient backcheck member which is deformably urged against annular valve seats by support members embodied in the housing opposite and central to the valved inlets. A conventional injection site may be provided in the housing so that additional fluids may be injected into the interior of the manifold through an inserted cannula.
    Type: Grant
    Filed: July 15, 1994
    Date of Patent: July 11, 1995
    Assignee: Pacific Device Inc.
    Inventors: William M. Shannon, Donald H. Koenig
  • Patent number: 5122517
    Abstract: Antiviral and antitumor compositions are disclosed comprising a mixture of AZT, ribavirin, d4T or CS-87 with a compound of general formula: ##STR1## wherein Z is H, OH or NH.sub.2, Y is CH, and X is selected from the group consisting of H, N(R).sub.2, SR, OR or halogen, wherein R is H, lower(C.sub.1 -C.sub.4)alkyl, aryl or mixtures thereof, and the pharmaceutically-acceptable derivatives thereof.
    Type: Grant
    Filed: November 13, 1990
    Date of Patent: June 16, 1992
    Assignee: Regents of the University of Minnesota
    Inventors: Robert Vince, William M. Shannon
  • Patent number: 5075109
    Abstract: A method of delivering a bioactive agent to an animal entailing the steps of encapsulating effective amounts of the agent in a biocompatible excipient to form microcapsules having a size ranging from between approximately one micrometer to approximately ten micrometers and admnistering effective amounts of the microcapsules to the animal. A pulsatile response is obtained, as well as mucosal and systemic immuity. Related compositions are also provided.
    Type: Grant
    Filed: March 18, 1988
    Date of Patent: December 24, 1991
    Assignees: Southern Research Institute, UAB Research Foundation
    Inventors: Thomas R. Tice, Richard M. Gilley, John H. Eldridge, Jay K. Staas, Melinda G. Hollingshead, William M. Shannon
  • Patent number: 4585482
    Abstract: There is disclosed, in one aspect, a long-acting biocidal composition. This composition comprises a chlorine dioxide-liberating compound, such as sodium chlorite, and sufficient organic acid-generating compound, such as poly(lactic acid), to lower the pH of the composition to less than about 7. The organic acid-generating compound is present in a form whereby it is released gradually in the presence of water. Preferably the organic acid-generating compound is encapsulated within or by a film-forming polymer. In another aspect, there is disclosed a method of disinfecting a surface over a prolonged period of time. This method comprises applying to the surface a small but effective amount of the long-acting biocidal composition described above.
    Type: Grant
    Filed: May 25, 1984
    Date of Patent: April 29, 1986
    Assignee: Southern Research Institute
    Inventors: Thomas R. Tice, William E. Meyers, Richard M. Gilley, William M. Shannon
  • Patent number: 4396623
    Abstract: There is provided a method for the treatment of viral infections by treating a host animal with a pharmaceutically effective amount of a carbocyclic analog of a nucleoside represented by Formula I: ##STR1## wherein X is chlorine, bromine, iodine, a lower alkyl group or an amino group of the formula --NHR.sup.2 wherein R.sup.2 is a lower alkyl group; and R and R' can be the same or different members selected from the group consisting of hydrogen, an alkanoyl group or an aroyl group.
    Type: Grant
    Filed: August 26, 1981
    Date of Patent: August 2, 1983
    Assignee: Southern Research Institute
    Inventors: Y. Fulmer Shealy, C. Allen O'Dell, William M. Shannon
  • Patent number: 4210639
    Abstract: 5'-Deoxy-5'-(isobutylthio)-3-deazaadenosine and a method for preparation of same. In the preparation, 3-deazaadenosine is utilized as a starting material and is chlorinated at the 5' position. Subsequently, the chloro group is converted to isobutylthio by reaction with isobutyl mercaptan in ethanol containing sodium methoxide giving the desired compound.A most preferred starting material, i.e., 3-deazaadenosine, was prepared according to the method of Montgomery et al, J. Heterocyclic Chem., 14:195 (1977). The key fusion of this process is 4,6-dichloroimidazo[4,5-c]pyridine with 1,2,3,5-tetra-O-acetyl-.beta.-D-ribofuranose, which, after removal of protective groups and reductive dechlorination of the chlorine at 6, gives 3-deazaadenosine.
    Type: Grant
    Filed: August 29, 1978
    Date of Patent: July 1, 1980
    Assignee: The United States of America as represented by the Department of Health, Education and Welfare
    Inventors: Peter K. Chiang, Guilio L. Cantoni, John P. Bader, William M. Shannon, H. Jeanette Thomas, John A. Montgomery